Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Industry News > Loss to follow-up interventions still lacking in patients with eye diseases
  • Industry News

Loss to follow-up interventions still lacking in patients with eye diseases

Ophthalmology 360

There is no single intervention proven to be effective in reducing loss to follow-up or fragmented follow-up episodes (LTFU) in patients with age-related macular degeneration, retinal vein occlusion, and diabetic macular edema, according to a study.

This may result in worse than expected clinical outcomes, especially when comparing real world data to clinical trials.

Using a literature search, 10 studies evaluating interventions designed to reduce loss to follow up were identified and analyzed.

Telephone calls aimed to help with follow-up scheduling were found to improve LTFU in older African American patients with diabetic retinopathy living in urban areas, but the same intervention is understudied in other eye diseases in patients with other demographics.

“A standardized definition of LTFU, as well as testing interventions across broad age, geography, ethnic, racial, and socioeconomic lines. Longitudinal data would also add credence to the efficacy of purported interventions,” concluded the authors

Reference
Muste JC, Russell MW, Iyer AI, et al. Interventions to reduce loss to follow up in common retinal pathology: A systematic review. Eur J Ophthalmol. 2022;11206721221145058. doi: 10.1177/11206721221145058. Epub ahead of print. PMID: 36537123.

Share

Related Content

  • Retina

Heidelberg receives FDA clearance for updated SPECTRALIS software

FDA approves Beovu label update to include safety information
  • Cataract

FDA approves first and only extended depth of focus IOL for cataract patients

  • Retina Care 360

Phase 3 SOL-1 trial results are a “landmark achievement” for investigational TKI therapy for wet AMD

  • Industry News

Topcon Healthcare partners with RemoniHealth on remote eye care

1 Min Read
  • Cornea and External Disease

DefEYE Inc launches as independent ophthalmic biologics company

  • Industry News

Harrow to acquire Melt Pharmaceuticals to expand non-opioid sedation options

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon